OTCM
SAPEF
Market cap306mUSD
, Last price
USD
Name
SAPPE PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sappe Public Company Limited, together with its subsidiaries, manufactures and globally distributes a diverse range of healthy food and beverage products, serving both the Thai domestic market and international customers. The company's operations are organized into two primary segments: Health Drinking Products and Coconut Products. Within its health beverage portfolio, Sappe offers zero-sugar drinks like Sappe Beauti Drink, vitamin-infused fruit water known as B'lue, instant coffee solutions such as Preaw Coffee and SlimFit Coffee, powdered chlorophyll under the Preaw Chlorophyll brand, and Maxtive Coffee, a specialized blend for men. Its coconut and fruit juice offerings include Sappe Aloe Vera (fruit juice with aloe vera in various flavors), Mogu Mogu (the original fruit juice containing coconut jelly), and fragrant coconut water under the All Coco brand. Additionally, Sappe markets a variety of snacks and desserts: health and beauty jellies like Sappe Beauti Jelly, ZeaMax grilled fish snacks, Maxtive energy jellies, DeNosh organic soy puddings in jelly format, Gumi Gumi Jelly (a fruit jelly snack with carrageenan and konjac), Preaw Pudding's ready-to-eat konjac puddings, and All Coco Pudding desserts. Previously known as Sapanan General Food Company Limited, the company officially changed its name to Sappe Public Company Limited in September 2013. Established in 1973, Sappe Public Company Limited is headquartered in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||